Skip to Content
Merck
All Photos(3)

Key Documents

View All Documentation

T85308

Sigma-Aldrich

Tris(2-chloroethyl)amine hydrochloride

98%

Sign Into View Organizational & Contract Pricing
All Photos(3)

About This Item

Linear Formula:
(ClCH2CH2)3N·HCl
CAS Number:
817-09-4
Molecular Weight:
240.99
EC Number:
212-442-3
MDL number:
MFCD00012520
UNSPSC Code:
12352100
PubChem Substance ID:
24900538
Product T85308 is not currently sold in your country. Contact Technical Service

Assay

98%

mp

127-130 °C (lit.)

SMILES string

Cl.ClCCN(CCCl)CCCl

InChI

1S/C6H12Cl3N.ClH/c7-1-4-10(5-2-8)6-3-9;/h1-6H2;1H

InChI key

VEAUDLLZYJVHRI-UHFFFAOYSA-N

Related Categories

Signal Word

Danger

Hazard Statements

H300,H314,H351

Hazard Classifications

Acute Tox. 2 Oral - Carc. 2 - Skin Corr. 1B

Storage Class Code

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKBR0330V
03230MH
01016HE
10729PW
01814BD

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

N I Ryabchenko et al.
General physiology and biophysics, 10(1), 41-48 (1991-02-01)
The dynamic of chromatin degradation was studied in thymocytes and LS/BL tumour cells. In permeabilised LS/BL cells, the rate of DNA degradation induced by endogenous calcium and magnesium-dependent endonuclease was approx. 25 times slower than in thymocytes. In LS/BL cells
I Koza et al.
Neoplasma, 36(6), 709-718 (1989-01-01)
Fifty-three patients with advanced Hodgkin's disease, most of them previously treated, received 8 to 16 courses of modified MOPP regimens (nitrogen mustard replaced by trichlormethine in arm A, with addition of vinblastine to the 4-drug regimen in arm B, and
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan.
L S Goodman et al.
JAMA, 251(17), 2255-2261 (1984-05-04)
I Sýkora et al.
Neoplasma, 28(5), 565-574 (1981-01-01)
The cytostatic TS-160 (trichloromethine hydrochloride, tris-/2-chloroethyl/amine hydrochloride) was injected subcutaneously into SPF Wistar rats of both sexes. After all doses used, spindle-cell or even polymorphocellular sarcomas developes at the injection sites in both sexes: after the dose of 0.1 mg/kg
D Slamenová et al.
Mutation research, 116(3-4), 431-440 (1983-03-01)
The cytostatic agent TS160 inhibited DNA synthesis in V79 cells while the course of RNA synthesis and protein synthesis were not changed significantly. DNA inhibition was in direct correlation with the inhibition of growth and reduction of colony-forming ability in
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service